hypothermic oxygenated perfusion

PROCEDURE2 trials

Sponsors

Philipp Dutkowski, Universitair Medisch Centrum Groningen

Conditions

End-stage liver diseaseHCCLiver TransplantationOncological Outcomes

Phase 3

A Multicenter Randomized Controlled Trial to Compare the Efficacy of End-ischemic Dual Hypothermic Oxygenated Perfusion with Standard Static Cold Storage of Liver Grafts Donated after Circulatory Death in Preventing Non-anastomotic Biliary Strictures after Transplantation

Active, not recruitingNL-OMON47263

Universitair Medisch Centrum GroningenEnd-stage liver disease

Start: 2016-01-07Target: 100Updated: 2024-02-28

Phase 4

HOPE Against Cancer Recurrence in HCC

RecruitingNCT06717919

Philipp DutkowskiHCC, Liver Transplantation, Oncological Outcomes

Start: 2025-08-01End: 2028-01-31Target: 220Updated: 2025-12-16

Related Papers

Hypothermic oxygenated perfusion (HOPE) against cancer recurrence after liver transplantation for hepatocellular carcinoma-study protocol for an international multicenter randomized controlled trial (HOPE4Cancer)

Universität Zürich, ZORA2025-09-26

Hypothermic oxygenated perfusion (HOPE) against cancer recurrence after liver transplantation for hepatocellular carcinoma-study protocol for an international multicenter randomized controlled trial (HOPE4Cancer).

2025-09-26